{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:28Z","timestamp":1786119328028,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/cej.0b013e32832e0955","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T05:08:13Z","timestamp":1249276093000},"page":"381-384","source":"Crossref","is-referenced-by-count":19,"title":["Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort"],"prefix":"10.1097","volume":"18","author":[{"given":"Piers A.","family":"Gatenby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Ramus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine P.","family":"Caygill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc C.","family":"Winslet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210128","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1158\/0008-5472.CAN-05-4253","article-title":"Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence","volume":"66","author":"Anderson","year":"2006","journal-title":"Cancer Res"},{"key":"R2-7-20210128","first-page":"119","article-title":"Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel","volume":"9","author":"Coogan","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R3-7-20210128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","article-title":"Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis","volume":"124","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"key":"R4-7-20210128","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1572-0241.2006.00626.x","article-title":"Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus","volume":"101","author":"De Jonge","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R5-7-20210128","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1371\/journal.pmed.0040067","article-title":"NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma","volume":"4","author":"Galipeau","year":"2007","journal-title":"PLoS Med"},{"key":"R6-7-20210128","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10620-007-0023-y","article-title":"Barrett's columnar-lined oesophagus: demographic associations and adenocarcinoma risk","volume":"53","author":"Gatenby","year":"2008","journal-title":"Dig Dis Sci"},{"key":"R7-7-20210128","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/jnci\/djk112","article-title":"Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial","volume":"99","author":"Heath","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R8-7-20210128","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jnci\/djh039","article-title":"Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus","volume":"96","author":"Hur","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R9-7-20210128","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1111\/j.1572-0241.2008.02117.x","article-title":"Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus","volume":"103","author":"Hur","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R10-7-20210128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1442-2050.2007.00684.x","article-title":"Effect of celecoxib on cyclooxygenase-2 expression and possible variants in a patient with Barrett's esophagus","volume":"20","author":"Jacobson","year":"2007","journal-title":"Dis Esophagus"},{"key":"R11-7-20210128","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jnci\/djh171","article-title":"Re: cost-effectiveness of aspirin chemoprevention for Barrett's esophagus","volume":"96","author":"Jankowski","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R12-7-20210128","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bpg.2006.04.009","article-title":"Etiology and risk factors for oesophageal adenocarcinoma: possibilities for chemoprophylaxis?","volume":"20","author":"Lagergren","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R13-7-20210128","first-page":"990","article-title":"Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence","volume":"96","author":"Morris","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R14-7-20210128","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1572-0241.2005.41338.x","article-title":"Proinflammatory cytokine and nuclear factor kappa-b expression along the inflammation\u2013metaplasia\u2013dysplasia\u2013adenocarcinoma sequence in the esophagus","volume":"100","author":"O'Riordan","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R15-7-20210128","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2036.2004.02150.x","article-title":"Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma","volume":"20","author":"Tsibouris","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R16-7-20210128","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S1470-2045(05)70431-9","article-title":"Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study","volume":"6","author":"Vaughan","year":"2005","journal-title":"Lancet Oncol"},{"key":"R17-7-20210128","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2168.2000.01498.x","article-title":"Barrett's oesophagus \u2013 50 years on","volume":"87","author":"Watson","year":"2000","journal-title":"Br J Surg"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0b013e32832e0955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:59:53Z","timestamp":1786039193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008469-200909000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0b013e32832e0955","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}